CID 16728438

Schembl5927667

Structural Information

Molecular Formula
C29H39BrClN7O5S2
SMILES
C1CNCCN(C1)S(=O)(=O)C2=CC(=C(N=C2)N3CCC(CC3)CCCC4CCN(CC4)S(=O)(=O)C5=C(C=CC6=NON=C65)Cl)Br
InChI
InChI=1S/C29H39BrClN7O5S2/c30-24-19-23(44(39,40)37-13-2-11-32-12-18-37)20-33-29(24)36-14-7-21(8-15-36)3-1-4-22-9-16-38(17-10-22)45(41,42)28-25(31)5-6-26-27(28)35-43-34-26/h5-6,19-22,32H,1-4,7-18H2
InChIKey
DKRHQKBHXLABTE-UHFFFAOYSA-N
Compound name
4-[4-[3-[1-[3-bromo-5-(1,4-diazepan-1-ylsulfonyl)pyridin-2-yl]piperidin-4-yl]propyl]piperidin-1-yl]sulfonyl-5-chloro-2,1,3-benzoxadiazole
Related CIDs

2D Structure

compound 2d structure
1
Annotation Hits

0
References

2
Patents

743.1326 Da
Monoisotopic Mass

4.7
XlogP (predicted)

Profile

Predicted Collision Cross Section

Adduct m/z Predicted CCS (Ų)
[M+H]+ 744.13988 232.4
[M+Na]+ 766.12182 238.2
[M-H]- 742.12532 240.4
[M+NH4]+ 761.16642 227.9
[M+K]+ 782.09576 231.4
[M+H-H2O]+ 726.12986 228.0
[M+HCOO]- 788.13080 221.4
[M+CH3COO]- 802.14645 235.3
[M+Na-2H]- 764.10727 231.8
[M]+ 743.13205 244.4
[M]- 743.13315 244.4
m/z: mass to charge ratio of the adduct.
Predicted Collision Cross Section (CCS) values (Ų) per adduct calculated using CCSbase.

Literature stripe

No literature data available for this compound.

Patent stripe

patents stripe